Időskori makuladegeneráció: nyitott vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 22 Also abroad 220

22 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.

2. fázisToborozTrial-stage medicine
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Bristol, London, Newcastle upon Tyne, Southampton
Age
50 év and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642EU 2025-523704-77-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Bristol, Gloucester, Leicester, London
Age
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542EU 2024-516924-32-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Bristol, Liverpool, London, Newcastle upon Tyne, York
Age
50 év to 85 év
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704EU 2023-509547-27-00Regiszter frissítve: 2026-11-05
2/3. fázisToborozTrial-stage medicine
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Bristol, Headington, London, Newcastle upon Tyne
Age
60 év and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148EU 2022-500747-21-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Bristol, Gloucester, Liverpool, London, Newcastle upon Tyne, Sunderland
Age
50 év and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065EU 2024-512298-28-00Regiszter frissítve: 2026-10-29
3. fázisToborozTrial-stage medicine
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Bristol, Liverpool, London, Newcastle upon Tyne, Sunderland, Wolverhampton
Age
50 év and over
People
1000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251EU 2023-507131-38-00Regiszter frissítve: 2026-10-27
1/2. fázisToborozTrial-stage medicine
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
London
Age
60 év and over
People
104 worldwide
Run by
Sanofi
See details and how to joinNCT07215234Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Bradford, London, Sunderland
Age
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759Regiszter frissítve: 2026-10-19
No phaseToborozResearch participation
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Where
Belfast, Frimley, Gloucester, London, Manchester, Southampton, Sunderland
Age
55 év and over
People
75 worldwide
Run by
Complement Therapeutics
See details and how to joinNCT07144137Regiszter frissítve: 2026-10-16
1/2. fázisToborozTrial-stage medicine
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
Where
Gloucester, London, Sunderland
Age
55 év and over
People
75 worldwide
Run by
Complement Therapeutics
See details and how to joinNCT07392255Regiszter frissítve: 2026-10-16
2/3. fázisToborozTrial-stage medicine
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Leicester, Liverpool, London
Age
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225Regiszter frissítve: 2026-10-02
2. fázisCsak meghívásosTrial-stage medicine
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Where
London, Sunderland
Age
55 év and over
People
225 worldwide
Run by
Gyroscope Therapeutics Limited
See details and how to joinNCT05481827EU 2024-510946-15-00Regiszter frissítve: 2026-09-28
2. fázisToborozTrial-stage medicine
A Study in Adults With Geographic Atrophy
Where
Leicester, London, Newcastle upon Tyne, Southampton
Age
60 év and over
People
300 worldwide
Run by
Sitala Bio LTD
See details and how to joinNCT07606365EU 2026-525738-40-00Regiszter frissítve: 2026-09-21
3. fázisToborozTrial-stage medicine
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Where
Belfast, Brighton, Bristol, Canterbury, Chelmsford, Edinburgh, Exeter, Glasgow, Hull, Leicester, Liverpool, London, Maidstone, Manchester, Middlesbrough, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Southampton, Sunderland, Torquay, Wolverhampton
Age
50 év to 120 év
People
210 worldwide
Run by
King's College Hospital NHS Trust
See details and how to joinNCT04663750EU 2023-504751-28-00Regiszter frissítve: 2026-09-11
2. fázisToborozTrial-stage medicine
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Belfast, Gloucester, London, Newcastle, Southampton, Sunderland, York
Age
55 év and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445EU 2024-513174-22-00Regiszter frissítve: 2026-09-10
2. fázisToborozTrial-stage medicine
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Dorchester, Liverpool, London, Sunderland, Wolverhampton
Age
60 év and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269EU 2025-521779-30-00Regiszter frissítve: 2026-09-03
No phaseToborozResearch participation
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Where
Belfast, London, Middlesex, Sunderland
Age
60 év and over
People
100 worldwide
Run by
i-Lumen Scientific AUS PTY LTD
See details and how to joinNCT06662162Regiszter frissítve: 2026-08-26
No phaseToborozResearch participation
Visual Frailty in Ageing
Where
Edinburgh
Age
60 év and over
People
20
Run by
University of Edinburgh
See details and how to joinNCT06604104Regiszter frissítve: 2026-03-04
No phaseCsak meghívásosResearch participation
Microperimetry Changes in Retinal Function in Macular Disorders
Where
Nottingham
Age
21 év and over
People
200
Run by
University of Nottingham
See details and how to joinNCT07170683Regiszter frissítve: 2025-09-12
No phaseToborozResearch participation
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Where
Belfast
Age
55 év to 99 év
People
200 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06351657Regiszter frissítve: 2025-05-15
No phaseToborozResearch participation
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Where
Belfast
Age
55 év to 99 év
People
500 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06351670Regiszter frissítve: 2025-05-15
No phaseCsak meghívásosResearch participation
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)
Where
Frimley, Harlow, London, Newport, Oxford, Salisbury, Southampton
People
300 worldwide
Run by
University of Southampton
See details and how to joinNCT06682455Regiszter frissítve: 2024-11-12

Minden vizsgálat (Időskori makuladegeneráció) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek